• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾素底物(血管紧张素原)制剂在测定前肾素和肾素中的应用:肾外血浆前肾素及其肾内“转化酶”的证据

Renin substrate (angiotensinogen) preparations in the determination of prorenin and renin: evidence for extrarenal plasma prorenin and its renal "convertase".

作者信息

Purdon A D, Loh A Y, Osmond D H

机构信息

Department of Physiology, Faculty of Medicine, University of Toronto, Ont., Canada.

出版信息

Can J Physiol Pharmacol. 1987 Nov;65(11):2319-28. doi: 10.1139/y87-368.

DOI:10.1139/y87-368
PMID:3329567
Abstract

Standard methods for determining prorenin-renin concentrations in plasma (PRC) and other tissues require the addition of exogenous renin substrate (angiotensinogen) to improve the kinetics of the renin reaction. We studied the effects of substrate prepared from normal human plasma fraction Cohn IV-4, or from nephrectomized (2NX) sheep plasma, on PRC of normal and 2NX human plasmas before and after prorenin activation by acid, cold, and trypsin, and compared the results with plasma renin activities (PRA, no added substrate). Plasmas from 2NX men exhibited negligible basal PRA, indicating that very little, if any, renin had been formed from the extrarenal prorenin they contained, and suggesting the lack of an endogenous prorenin activating mechanism, or "convertase," of probable renal origin. Prorenin was demonstrable by tryptic activation, more than by acid or cold, at up to about 30% of normal. Addition of Cohn IV-4 substrate to 2NX plasma unexpectedly produced (i) a basal PRC value higher than in normal plasma, (ii) total renin values after activation by acid, cold, and trypsin that were much closer to normal values than reflected by PRA methodology, without a commensurate increase (if anything a decrease) in prorenin as a percentage of total renin estimated by all activation methods, and (iii) substantial equalization of activation effects such that trypsin was no longer more effective than acid and cold (and this was also noted with normal plasma). The skewing effect of adding Cohn IV-4 substrate on the PRC of 2NX plasma was much greater than in normal plasma, even though 2NX plasma already had an above normal level of endogenous substrate and should have been influenced less. Enhancement of PRC was very pronounced even when Cohn IV-4 was added to make up only 9% of total (endogenous + exogenous) substrate in the incubation system, suggesting that it was not the added substrate but a renin-generating contaminant that inflated the PRC. Such inflation could be blocked by adding protease inhibitors, suggesting that the responsible protease(s) acted as a prorenin "convertase" that generated new renin from renal and (or) extrarenal prorenin contributed by the added substrate, as well as by the plasma being assayed. One component of convertase could be kallikrein, which was identified by chromogenic assay, the importance of which relative to total convertase activity is unknown.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

测定血浆(PRC)和其他组织中前肾素 - 肾素浓度的标准方法需要添加外源性肾素底物(血管紧张素原)来改善肾素反应的动力学。我们研究了从正常人血浆组分Cohn IV - 4或肾切除(2NX)绵羊血浆制备的底物对正常人和2NX人血浆在酸、冷和胰蛋白酶激活前肾素前后PRC的影响,并将结果与血浆肾素活性(PRA,未添加底物)进行比较。2NX男性的血浆显示出可忽略不计的基础PRA,这表明他们所含的肾外前肾素极少形成肾素,提示可能缺乏源自肾脏的内源性前肾素激活机制或“转化酶”。通过胰蛋白酶激活可检测到前肾素,其检测效果比酸或冷激活更明显,可达正常水平的约30%。向2NX血浆中添加Cohn IV - 4底物意外产生了以下结果:(i)基础PRC值高于正常血浆;(ii)经酸、冷和胰蛋白酶激活后的总肾素值比PRA方法所反映的更接近正常水平,且所有激活方法估计的前肾素占总肾素的百分比没有相应增加(甚至有所下降);(iii)激活效果基本均衡,使得胰蛋白酶不再比酸和冷更有效(正常血浆也有此现象)。添加Cohn IV - 4底物对2NX血浆PRC的偏差影响比正常血浆大得多,尽管2NX血浆内源性底物水平已高于正常,本应受影响较小。即使在孵育系统中添加Cohn IV - 4仅占总(内源性 + 外源性)底物的9%时,PRC的增强也非常明显,这表明使PRC升高的不是添加的底物,而是一种产生肾素的污染物。添加蛋白酶抑制剂可阻断这种升高,这表明相关蛋白酶作为前肾素“转化酶”,从添加底物以及被测血浆中所含的肾脏和(或)肾外前肾素产生新的肾素。转化酶的一个成分可能是激肽释放酶,通过显色测定法已鉴定出激肽释放酶,但其相对于总转化酶活性的重要性尚不清楚。

相似文献

1
Renin substrate (angiotensinogen) preparations in the determination of prorenin and renin: evidence for extrarenal plasma prorenin and its renal "convertase".肾素底物(血管紧张素原)制剂在测定前肾素和肾素中的应用:肾外血浆前肾素及其肾内“转化酶”的证据
Can J Physiol Pharmacol. 1987 Nov;65(11):2319-28. doi: 10.1139/y87-368.
2
Effects of pregnancy, oral contraception, and binephrectomy, on human plasma "prorenin" and its activator(s).妊娠、口服避孕药和双侧肾切除对人血浆“肾素原”及其激活剂的影响。
Clin Exp Hypertens A. 1982;4(11-12):2385-402. doi: 10.3109/10641968209062397.
3
Plasma prorenin in humans and dogs. Species differences and further evidence of a systemic activation cascade.人类和犬类的血浆肾素原。种属差异及系统性激活级联反应的进一步证据。
Hypertension. 1983 May-Jun;5(3):277-85. doi: 10.1161/01.hyp.5.3.277.
4
Peculiarities of plasma "prorenin" measurements in man, dog, and rat, and their theoretical implications.人、狗和大鼠血浆“肾素原”测量的特点及其理论意义。
Clin Exp Hypertens A. 1982;4(11-12):2213-30. doi: 10.3109/10641968209062385.
5
New renin--angiotensin from plasma prorenin?血浆中血管紧张素原能否产生新的肾素 - 血管紧张素?
Am J Hypertens. 1990 Mar;3(3):196-203. doi: 10.1093/ajh/3.3.196.
6
Extrarenal prorenin in plasma requires an activator of renal origin.血浆中的肾外肾素原需要一种肾源性激活剂。
Hypertension. 1986 Jun;8(6 Pt 2):II84-8. doi: 10.1161/01.hyp.8.6_pt_2.ii84.
7
Evidence for beta-adrenergic regulation of renal and extrarenal plasma prorenin and renin in dogs.犬肾及肾外血浆中血管紧张素原和肾素的β-肾上腺素能调节证据。
Proc Soc Exp Biol Med. 1986 Jun;182(2):208-14. doi: 10.3181/00379727-182-42329.
8
Effect of angiotensinogen concentration on renin activity following nephrectomy and adrenalectomy: implications in the activation of plasma prorenin.肾切除和肾上腺切除后血管紧张素原浓度对肾素活性的影响:对血浆肾素原激活的意义。
Clin Exp Hypertens A. 1990;12(8):1473-87. doi: 10.3109/10641969009073531.
9
Immunoreactive renin, prorenin, and enzymatically active renin in plasma during pregnancy and in women taking oral contraceptives.孕期及服用口服避孕药女性血浆中的免疫反应性肾素、肾素原和酶活性肾素。
J Clin Endocrinol Metab. 1986 Oct;63(4):1008-15. doi: 10.1210/jcem-63-4-1008.
10
Activation and measurement of plasma prorenin in the rat.大鼠血浆肾素原的激活与测定
Can J Physiol Pharmacol. 1991 Sep;69(9):1331-40. doi: 10.1139/y91-197.